1. Introduction {#Section1}
===============

Gliomas are the most common type of primary malignant brain tumor[@B1]-[@B2], accounting for nearly 80% of the cases[@B3]. The treatment modalities for glioma generally encompass of surgical resection, followed by adjuvant chemotherapy and radiotherapy [@B4]-[@B5]. Despite aggressive multimodal treatment regimens, the survival of patients with glioma remains dismal[@B6]-[@B7], mainly due to its inevitable progression and relapse after initial treatment[@B2], [@B8]-[@B9].

Frequently reported determinants of tumor-related outcomes for glioma patients include patient related factors, such as age[@B10]-[@B11] and performance status[@B12], and tumor-related characteristics, such as histopathological characteristics[@B2],[@B11], tumor size[@B13]-[@B16] and location[@B16]-[@B18]. Although there are some evidences supporting the significant associations between tumor characteristics and the survival of gliomas, most studies failed to find any relation. The prognostic value of tumor characteristics is widely considered controversial[@B19], partly because of a lack of knowledge regarding the mechanisms of how these associations develop.

It is relatively straightforward to figure out how some tumor characteristics influence the hazard of death from glioma. For example, the WHO classification of tumors represents a \'malignancy scale\' grading scheme[@B20]; low-grade gliomas are characterized by a lack of endothelial proliferation and necrosis[@B21]. Contrast enhancement on MRI is a specific radiologic feature, has been thought to imply blood-brain barrier is disturbed by invasive tumor cells and suggest a poorer prognosis for glioma[@B22]. Larger tumors may have an increasing proliferative ability leading to increasing tumor burden, and subsequently worse survival time[@B23]. Nevertheless, there may be other factors that mediate the relationship between tumor characteristics and the hazard of death from glioma.

In this study, the extent of resection (EOR) is proposed as a potential mediator in the association between some tumor characteristics and the hazard of death from glioma. Recent researches emphasize the importance of EOR for survival of glioma [@B3], [@B6], [@B24]; maximal safe resection is considered effective to significantly improve survival of gliomas [@B3], [@B9]. Glioma is known for its infiltrative property; however it is difficult to distinguish the tumor tissue from adjacent normal brain tissue[@B25]. Complete resection has been found to be more likely to be achieved in patients with more favorable tumor characteristics[@B26], such as lack of contrast enhancement and smaller tumor size[@B26]-[@B27]. The glioblastoma multiform (GBM) lesions tend to be irregular in shape and usually include cystic areas, which leads to a lower probability of achieving gross total resection (GTR) [@B15]. Because neurosurgery may not be always feasible because of some tumor locations, it is more likely that GTR be achieved in supratentorial if compared to infratentorial tumors[@B28]. As a consequence, residual tumor cell dissemination beyond the margins of resection and resistance to conventional adjuvant therapies lead to the inevitable relapse and increasing hazard of death of glioma[@B29]. Whether tumor characteristics plays an indirect role in gliomas survival through the extent of surgical resection remains to be seen.

Given the significant associations between tumor characteristics, extent of resection, the progression (relapse) and outcome (death) of glioma, it is reasonable to hypothesize the extent of resection may mediate the relationship between tumor characteristics and the hazard of death from glioma. However, to the best of our knowledge, no study has investigated this relation. And it is difficult to estimate the indirect effects using conventional survival model such as Cox regression [@B30]-[@B31]. In this study, the discrete-time survival model integrated with the survival outcomes within structural equation models[@B30], [@B32] was employed to develop and test a more comprehensive hypothesis regarding the direct and indirect roles of tumor characteristics on the hazard of death from glioma, mediated by the extent of resection.

2. Patients and Methods {#Section2}
=======================

2.1 Study population {#Section2.1}
--------------------

This consecutive study retrospectively included a group of 421 treatment-naive patients with newly and pathologically confirmed glioma between January 2004 and December 2014. Patients who had prior history of malignancy or second primary tumor, acute infection or autoimmune diseases, or patients with perioperative surgery-related mortality have been excluded. Clinical information was collected at baseline and regularly updated through follow up. Finally, 28 of these 421 patients have been excluded according to the enrollment criteria, and 393 patients with adequate clinical information were eligible for this study.

2.2 Data collection {#Section2.2}
-------------------

Information on patient age, gender, Karnofsky Performance Status (KPS), tumor grade, tumor size, tumor location, presence or absence of contrast enhancement on MRI and extent of tumor resection were collected. The tumor grade of glioma was determined on pathological specimens according to World Health Organization (WHO) international histological classification of central nervous (CNS) tumors[@B20]. Gliomas with WHO grade I and II were classified as low grade gliomas, whereas gliomas with grade III and IV were classified as high grade gliomas. Pretreatment contrast-enhanced MRI was performed to obtain the tumor size (the maximum diameter of the glioma) and the presence or absence of contrast enhancement on MRI. Tumor location was categorized as supratentorial and infratentorial areas. The extent of tumor resection was assessed by neurosurgeons according to postoperative MRI. The extent of resection was classified as gross total resection (GTR) or sub-total resection (STR).

Chemotherapy and radiotherapy were recommended as adjuvant therapies after primary tumor resection surgery. Due to economic and general condition reason, a portion of these 393 patients did not receive adjuvant therapy.

Repetitive MRI scan was regularly recommended to study patients, and the information on relapse and survival was updated semiannually through follow-up. Relapse was identified according to latest radiographic evidence. Patients were followed until death or censoring at the end of the study (October 2015). Progression-free survival (PFS) was defined as the time from diagnosis to relapse, death from glioma, or the date of the last follow-up visit.

2.3 Ethical statement {#Section2.3}
---------------------

All patients of this study have been provided written informed consent. This study was conducted with the approval of the medical ethics committees, and in accordance with the principles of the Declaration of Helsinki.

2.4 Model specification {#Section2.4}
-----------------------

A hypothesis was established that characteristics of glioma such as tumor grade, tumor size, tumor location, and contrast enhancement may influence the extent of resection. And tumor characteristics, the extent of resection, and radiotherapy and chemotherapy have a direct impact on the survival of glioma. And the indirect effect of tumor characteristics on PFS of glioma through extent of resection was explored, as shown in Fig. [1](#F1){ref-type="fig"}.

2.5 Statistical analyses {#Section2.5}
------------------------

Data analyses were performed using the SPSS 21.0 (IBM, Chicago) and Mplus 7.4 (Muthén & Muthén, Los Angeles) software package. In this study, time-to-event data for glioma relapse or death was modeled using a discrete-time survival model, the relapse or survival time was measured continuously before being subsequently transformed into discrete annual intervals. A series of patients with pathologically confirmed and treatment-naive glioma between January 2004 and December 2014 was followed up till October 2015 in this study. This implied a minimum of 1 and a maximum of 12 annual intervals have been observed in our study, and we truncated at 10 as the number of death per year turned negligible after this point.

The latent hazard variable underlying 10 binary time-specific event indicators was described in right part of Fig. [1](#F1){ref-type="fig"}. Each event indicator had a value of 1 if it (relapse or death for PFS) occurred during this time period and 0 if otherwise. The remaining event indicators were encoded as missing once the event occurred or the patient was lost to follow-up. Ages, genders and KPSs of all patients were included in the model as covariates. The model was analyzed using Maximum Likelihood estimator, and the standard errors (SE) for the indirect effects were estimated using the delta method[@B30].

3. Results {#Section3}
==========

3.1 Patient characteristics and survival outcome {#Section3.1}
------------------------------------------------

The characteristics of study patients were presented in Table [1](#T1){ref-type="table"}. The majority of these patients were males (58.8%), aged less than 60 years (86.8%), had a KPS score larger than 80 (82.7%). According to WHO international histological classification of central nervous (CNS) tumors, 251 (63.9%) of the patients were diagnosed with high grade gliomas (WHO grade III and IV). Tumor size was less than 5 cm in 289 (73.5%) patients. Tumor location was categorized as supratentorial areas in 359 (91.3%) patients, and infratentorial areas in 34 (8.7%) patients. The presence of contrast enhancement on MRI was observed in 336 (85.4%) patients. GTR was achieved in 285 (72.5%) patients. Adjuvant chemotherapy was undertaken in 132 (33.6%) patients, and adjuvant radiotherapy was undertaken in 174 (44.3%) patients.

By the end of the study period, 215 (54.7%) patients had died. The median OS of all the patients was 18.0 months, and the median PFS was 8.3 months.

3.2 Discrete-time survival model (Fig. [1](#F1){ref-type="fig"}) {#Section3.2}
----------------------------------------------------------------

### 3.2.1 Direct effects {#Section3.2.1}

The model suggests a significant direct effect of tumor characteristics on PFS of glioma. The direct path coefficients were marked in Fig. [1](#F1){ref-type="fig"} and relevant information were shown in Table [2](#T2){ref-type="table"}. The model indicated that high grade glioma has led to a substantial increase in the hazard of 0.276 SD (compare to low grade glioma). The presence of contrast enhancement led to an increase in the hazard of 0.194 SD, having glioma sited in infratentorial areas (0.088 SD) rather than supratentorial areas were independently and directly associated with increased hazard. GTR reduced the hazard considerably (-0.428 SD, compare to STR).

High grade glioma (-0.162SD) had a lower probability of achieving GTR when compared against its low grade counterpart. The presence of contrast enhancement led to a decrease of 0.519 SD in the probability of achieving GTR. In addition, larger tumor size lower the probability of GTR (-0.483 SD).

### 3.2.2 Indirect effects {#Section3.2.2}

The indirect effects of tumor characteristics on PFS of glioma through extent of resection were shown in Table [2](#T2){ref-type="table"}. High grade glioma, the presence of contrast enhancement, large tumor size indirectly increased the hazard by reducing the extent of resection. The indirect effect suggested that the presence of contrast enhancement was significantly associated with an increase in the hazard of 0.222 SD through extent of resection. In addition to the substantial direct effect of contrast enhancement on PFS of glioma, there was indirect effect that account for more than half of the total effect (53.4%).

4. Discussion {#Section4}
=============

A structural equation model with a discrete-time survival outcome was used to estimate both the direct effects of tumor characteristics on hazard of death from glioma and the mediating effects of extent of resection in this study. Finding of this study provided a better understanding of the process through which tumor characteristics are associated with hazard of death from glioma.

In the model, high-grade glioma, the presence of contrast enhancement, and infratentorial glioma were found associated with increased hazard directly. Previous studies reported the associations between these tumor characteristics and the survival of glioma using routine survival analysis method (Log-rank test or Cox regression) [@B11]-[@B13], [@B16]. However, the direct and indirect effect paths have not been depicted in existing studies and inter-associations between different tumor characteristics have not been taken into account. The significant inter-relations among tumor grade, contrast enhancement, tumor location and tumor size were also found in this study.

Although there were studies suggesting the role of extent of resection in the process through which tumor characteristics were associated with the hazard of death from glioma[@B26], no previous study had proven these assumptions using proper statistical models. This study provides concrete evidence that high-grade glioma, contrast enhancement and large tumor size have an indirect influence on the hazard of death from glioma, and that the extent of resection\'s role as the mediator. Extent of resection in glioma of surgery significantly contributes to an increasing hazard of death caused by unfavorable tumor characteristics. Previous studies have suggested that the contrast enhancement and larger tumor size may influence the extent of resection[@B26]-[@B27], and that the extent of resection as an important predictor for relapse and survival of glioma. Although it is not difficult to analyze these relationships separately in common statistical methods (logistic regression, Cox regression), the possible effect pathway among these factors cannot be explored integrally without newly suitable statistical model. Besides the essential direct effect, contrast enhancement was found to have a strong indirect effect on the hazard of death from glioma through the extent of resection. Larger contrast enhancement areas tend to cause more damages to normal brain tissues and immature blood vessels. Previous study found tumors with small contrast enhancing area showed lower ratios of necrosis, and were more likely to undergo GTR[@B26]. PFS of glioma could be improved by increasing the extent of resection for tumors with contrast enhancement.

In this study, linear probability model was used for the equation in which the mediator (extent of resection) is the dependent variables[@B30]. The estimated R-square for extent of resection is 29.4% in this model, which means 29.4% of the variance of extent of resection explained by tumor characteristics be analyzed. However, the R-square for survival outcome is not defined in this model, because the residual variance is zero for categorical latent hazard variable. Although it is difficult to estimate the degree of determination of tumor characteristics to the survival outcome, the R-square value for extent of resection was not very high. As the survival outcome was highly determined by the extent of resection, there might exist some possible improvable determinants, which could hopefully improve the extent of resection and so as to the survival outcome. More possibly improvable determinants for the extent of resection in addition to the tumor characteristics are probably beyond the scope of this paper but will definitely be explored in our future studies. Several recent studies have analyzed the relationship between IDH1 status/extent of resection and survival and have shown that patients with negative IDH1 benefit less from surgery[@B33]-[@B34]. Therefore, molecular markers such as IDH mutation status, 1p/19q mutation status, and MGMT methylation should be included in the model in future analyses.

The models used in this study provided us a method to take a closer look at the mediation effect related to survival of glioma, and yielded more refined and powerful explanation regarding the relation between prognostic factors and survival of glioma.

However, it is worth noting that there are still some issues not covered in our study. Firstly, the moderate sample size of our study suggests that some selection bias may exist. However, the data collection on such a sample size for survival of glioma is by no means easy and valuable information has been unveiled from this data set. Secondly, information of PFS might not be accurate, quantification of PFS is very difficult to obtain. Thirdly, the generalization in this study may not be concurrent with that of other studies. Future large longitudinal studies should be conducted to increase the generalizability of this study.

In this study, the indirect effects of tumor characteristics on survival of glioma through the extent of resection were found to be statistically significant and substantial in size. It reminds us that there is a risk of underestimating the comprehensive impact of tumor characteristics on survival outcome if the direct effects are solely focused. Instead of replicating analyses of the associations between prognostic factors and survival outcome of glioma in an endless series of samples, this approach encourages the progressive enrichment of an explanatory model.

Conclusion
==========

Extent of resection may be the factor that mediates the relation between tumor characteristics and the hazard of death from glioma. A lack of knowledge or understanding of the mediation effects may lead to a neglect of the influence of certain variables and impede a full appreciation of their role in determining outcomes. The findings of this study provide a better understanding of the process through which tumor characteristics are associated with hazard of death from glioma.
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###### 

Characteristics of study patients

  Variable                      Number   \%
  ----------------------------- -------- ------
  Gender                                 
  Males                         231      58.8
  Females                       162      41.2
  Age group (years)                      
  ≤60                           341      86.8
  \>60                          52       13.2
  KPS                                    
  ≤80                           68       17.3
  \>80                          325      82.7
  WHO grade                              
  I/II                          142      36.1
  III/IV                        251      63.9
  Tumor Size (cm)                        
  ≤5                            289      73.5
  \>5                           104      26.5
  Tumor Location                         
  Supratentorial                359      91.3
  Infratentorial                34       8.7
  Contrast enhancement on MRI            
  Yes                           336      85.4
  No                            57       14.6
  Extent of resection                    
  GTR                           285      72.5
  STR                           108      27.5
  Chemotherapy                           
  Yes                           132      33.6
  No                            261      66.4
  Radiotherapy                           
  Yes                           174      44.3
  No                            219      55.7

###### 

The direct and indirect effect of tumor characteristics on PFS of glioma (Fig. [1](#F1){ref-type="fig"})

  Variable                                                       Estimated effect   S.E.    Est./S.E.   p-value
  -------------------------------------------------------------- ------------------ ------- ----------- ---------
  ***Direct effects***                                                                                  
  Hazard of death due to glioma (PFS)                                                                   
  Tumor grade (III+IV/I+II)                                      0.276              0.064   4.315       \<0.001
  Contrast enhancement (Yes/No)                                  0.194              0.059   3.304       0.001
  Tumor size (\>5cm/≤5cm)                                        -0.013             0.049   -0.273      0.785
  Tumor location (Infratentorial/Supratentorial)                 0.088              0.024   3.659       \<0.001
  Extent of resection (GTR/STR)                                  -0.428             0.060   -7.177      \<0.001
  Chemotherapy (Yes/No)                                          0.008              0.029   0.293       0.769
  Radiotherapy (Yes/No)                                          -0.296             0.178   -1.663      0.096
  Age                                                            0.547              0.069   7.949       \<0.001
  Gender (Male/Female)                                           -0.018             0.034   -0.533      0.594
  KPS                                                            -0.036             0.061   -0.598      0.550
  Extent of resection (PFS)                                                                             
  Tumor grade (III+IV/I+II)                                      -0.162             0.080   -2.009      0.045
  Contrast enhancement (Yes/No)                                  -0.519             0.088   -5.883      \<0.001
  Tumor size (\>5cm/≤5cm)                                        -0.483             0.084   -5.763      \<0.001
  Tumor location (Infratentorial/Supratentorial)                 -0.092             0.074   -1.244      0.213
  Age                                                            -0.061             0.063   -0.983      0.325
  Gender (Male/Female)                                           0.033              0.050   0.662       0.508
  KPS                                                            -0.325             0.074   -4.390      \<0.001
  ***Indirect effects***                                                                                
  Tumor grade→Extent of resection→Latent hazard (PFS)            0.069              0.036   1.911       0.056
  Contrast enhancement→Extent of resection→Latent hazard (PFS)   0.222              0.051   4.325       \<0.001
  Tumor size→Extent of resection→Latent hazard (PFS)             0.207              0.048   4.308       \<0.001
  Tumor location→Extent of resection→Latent hazard (PFS)         0.039              0.032   1.216       0.224
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